Podoplanin overexpression as predictive marker of dysplasia in oral leukoplakia

Key Points

• Podoplanin overexpression predicts dysplasia in oral leukoplakia, indicating potential for early detection.
• Key evidence includes a significant correlation between podoplanin levels and dysplastic changes in tissue samples.
• Assessment involved examining podoplanin expression levels in biopsy specimens of oral leukoplakia lesions.
• This finding highlights the importance of podoplanin as a diagnostic biomarker for dysplasia in oral health.